In vitro chemo-sensitivity of B-chronic lymphocytic leukaemia to ara-G

References 

1. Verhoef V, Fridland A. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. Cancer Res. 1985;45:3646
   • MEDLINE
2. Fridland A, Verhoef V. Metabolism and selectivity of arabinonucleoside in human lymphoid cells. Proc. Soc. Biol. Med. 1985;179:456
3. Gandhi V, Plunkett W, Rodriguez COJ, Nowak BJ, Ayres M, Kisor DF, et al. Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. J. Clin. Oncol. 1998;16:3607
   • MEDLINE
4. Bromidge TJ, Howe DJ, Johnson SA, Phillips MJ. Adaptation of the TdT assay for semi-quantitative flow cytometric detection of DNA strand breaks. Cytometry. 1995;20:257
   • MEDLINE
   • CrossRef
5. Binet JL, Auquier A, Dighiero G, et al.  A new prognostic classification of chronic lymphocytic leukemia derived from a multi-variate survival analysis. Cancer. 1981;48:198
   • MEDLINE
   • CrossRef
6. Bromidge TJ, Turner DL, Howe DJ, Johnson SA, Rule SAJ. In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues-correlation with clinical course. Leukemia. 1998;12:1230
   • MEDLINE
7. Koski T, Vilpo L, Vilpo J. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-β-d-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia. Leuk. Res. 1999;23:277
   • Abstract
   • Full Text
   • Full-Text PDF (56 KB)
   • CrossRef
8. Bosanquet AG, Bell PB. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia. Blood. 1996;87:1962
   • MEDLINE